We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Pfizer Inc | NYSE:PFE | NYSE | Common Stock |
| Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|
| -0.67 | -2.38% | 27.49 | 28.49 | 27.40 | 28.31 | 65,588,937 | 00:59:52 |
From May 2019 to May 2024
AstraZeneca PLC (AZN) is working with banks on a possible plan to sell the rights to some future revenue from existing drugs, the Financial Times reported Friday, citing people familiar with the matter.
The plan is one of several strategic options the company is considering, according to the report.
AstraZeneca Chief Executive Pascal Soriot has said he is looking at ways to boost the U.K. drug maker's share price after fighting off a takeover effort by Pfizer Inc. (PFE), including forming cancer-treatment partnerships with rivals and making its own acquisitions.
Website: www.ft.com
Write to nymonitoring@dowjones.com
Subscribe to WSJ: http://online.wsj.com?mod=djnwires
1 Year Pfizer Chart |
1 Month Pfizer Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
